The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405.
 
Volker Heinemann
Honoraria - Amgen; Bayer; Merck Serono; Roche Pharma AG; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Roche Pharma AG; Sanofi
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche Pharma AG; Sanofi
 
Donna Niedzwiecki
No Relationships to Disclose
 
Rachel V. Pearline
No Relationships to Disclose
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical
Speakers' Bureau - Genomic Health
 
Richard M. Goldberg
Honoraria - Biothera; Lilly; Sanofi
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Merck KGaA; Sanofi
 
Federico Innocenti
Consulting or Advisory Role - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Royalties from the Mayo Foundation on the UGT1A1 testing
 
Robert J. Mayer
Honoraria - Amgen; AstraZeneca
 
Richard L. Schilsky
No Relationships to Disclose
 
Charles David Blanke
Travel, Accommodations, Expenses - Novartis
 
Monica M. Bertagnolli
No Relationships to Disclose
 
Alan P. Venook
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Onyx (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Halozyme; Merck Serono; Roche
 
Sebastian Stinzing
Honoraria - Amgen; Bayer; Merck Serono; Roche/Genentech; Sanofi
Consulting or Advisory Role - Merck Serono; Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche Pharma AG; Sanofi
 
Bert H. O'Neil
Consulting or Advisory Role - Acceleron Pharma; Amgen; Genentech/Roche; Lilly/ImClone; Sanofi
Speakers' Bureau - Amgen
Research Funding - Novartis (Inst)